Market Introduction
Allergen immunotherapy, also known as hypo-sensitization or desensitization, is a medical treatment for allergies. Measured doses of allergens are given to the patient resulting in reduced inflammation, which causes immune system to become less sensitive to the substance by blocking antibody function. Allergy immunotherapy primary therapeutic goals include reducing symptoms, reducing symptomatic medication use, and improving allergy-related quality of life.
Market Overview and Dynamics
The Europe allergy immunotherapies market is expected to grow owing to key driving factors such as the increasing prevalence of allergic disorders and technological advancements in sublingual dosage formulations. However, drawbacks associated with the use of allergy immunotherapies, restricted healthcare spending and regulatory variations across regions is likely to hamper the growth of the market during the forecast period.
Key Market Segments
The Europe allergy immunotherapies market, based on treatment, the SCIT segment held a larger share of the market in 2019. However, the SLIT segment is expected to register a higher CAGR in the market during the forecast period. The Europe allergy immunotherapies market, based on allergy type, the allergic rhinitis segment held the largest share of the market in 2019 and is anticipated to grow at a significant CAGR during forecast period. In 2019, the hospital pharmacy segment held the largest share of the market. Based on distribution channel, the hospital pharmacy segment held the largest share of the market in 2019 and is expected to register a higher CAGR in the market during the forecast period.
Major Sources and Companies Listed
Some of the major primary and secondary sources for Europe allergy immunotherapies market included in the report are Celsion Corporation, European and Developing Countries Clinical Trials Partnership (EDCTP), EuropaBio European Federation of Biotechnology (EFB) and European Academy of Allergy and Clinical Immunology.
Reasons to buy the report
EUROPE ALLERGY IMMUNOTHERAPIES MARKET SEGMENTATION
Europe Allergy Immunotherapies Market – By Treatment
Europe Allergy Immunotherapies Market – By Allergy Type
Europe Allergy Immunotherapies Market – By Distribution Channel
Europe Allergy Immunotherapies Market – By Country
Company Profiles
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 544.14 Million |
| Market Size by 2027 | US$ 1,228.14 Million |
| CAGR (2019 - 2027) | 10.8% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Treatment
|
| Regions and Countries Covered |
Europe
|
| Market leaders and key company profiles |
|
The Europe Allergy Immunotherapies Market is valued at US$ 544.14 Million in 2019, it is projected to reach US$ 1,228.14 Million by 2027.
As per our report Europe Allergy Immunotherapies Market, the market size is valued at US$ 544.14 Million in 2019, projecting it to reach US$ 1,228.14 Million by 2027. This translates to a CAGR of approximately 10.8% during the forecast period.
The Europe Allergy Immunotherapies Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Allergy Immunotherapies Market report:
The Europe Allergy Immunotherapies Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Allergy Immunotherapies Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Allergy Immunotherapies Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Allergy Immunotherapies Market
